SanaClis is heading for four European spring conferences
Press Release | SanaClis s.r.o.
APRIL 10, 2018
Bratislava, Slovakia: – Award-winning full service CRO SanaClis has announced plans to attend four leading clinical trials-oriented events around Europe during April 2018.
Ahead of its appearance at the Evolution Spring Summit in Miami in early May, Marcus Evans will organize the one-day Exclusive Customized Event for SanaClis, held in Vienna on April 11. “This event will discuss clinical trials case studies from Sponsor, Investor (VC), Investigator and CRO perspectives,” commented SanaClis Managing Partner Alexander Fetkovsky, who will represent the organization in Vienna.
Alex Fetkovsky; who is a member of the SanaClis Board, has an extensive career in the CRO and cold chain management industry. He has overall responsibility for the planning and execution of strategic initiatives and business partnering, as well as operational and financial oversight for multiple clinical programs and clinical trial supply/warehouse operations.
The following day, SanaClis will appear in Amsterdam at the 3rd Global Bioequivalence (BE) Harmonization (GBH) Initiative Conference. The two-day GBHI event will open April 12 at the Hotel Novotel in Amsterdam, Amsterdam, Netherlands . As SanaClis has very unique expertise in running clinical studies in the field of specialty and added value generics we consider this event as very unique opportunity to meet the industry peers and discuss mutual opportunities.
The event is organized by the European Federation for Pharmaceutical Sciences, with further information at: http://www.eufeps.org/conferences/3rd_GBHI.
“This will be our first appearance at this important event,” said Alexander Fetkovsky. “We decided to participate since bioequivalence studies are important in broadening both our professional and business horizons.”
“We see it as a great opportunity to meet with industry professionals, regulators and scientists from the pharmaceutical industry and exchange our experience and views and to take part in discussions about BE-related topics,” he added.
The following week SanaClis will move on to Warsaw to take part in the two-day Conference on Clinical Trials in Central and Eastern Europe (CEE), opening April 17 at the InterContinental Warszawa Hotel in the Polish capital.
Organized by Adam Smith Conferences
(www.clinicaltrialscee.com), the conference will provide SanaClis with the opportunity to share knowledge and insights with fellow industry professionals and regulators involved in clinical trials, focusing on CEE region including recent changes in EU regulatory requirements, such as protection of personal data.
On the last week of April, SanaClis will participate as a sponsor in 9th Clinical Trials Innovation Programme, which will take place on April 26-27 at Höchster Hof Hotel in Frankfurt, Germany. “We look forward to two days of interactive sessions and panel discussions in Frankfurt” Alexander said. “It is always a pleasure and a good experience to meet industry professionals and exchange the point of view on the key challenges that the pharma industry is facing at the moment.” he added.
SanaClis will use all of these events to show how its full service clinical trial support solutions help to deal with many of the issues under discussion.
SanaClis is a full-service European CRO offering a comprehensive range of services for clinical trials.
SanaClis has experience of successfully delivering studies for various sized sponsors, starting from virtual biotechs through to top 10 pharma companies. Every project is a priority for the SanaClis team, irrespective size or scope. We believe that every company and professional deserves to feel that they are getting the best possible service, responsiveness and dedication that we routinely provide to our existing clients.
In additional to being a full service CRO, SanaClis is one of the very few service providers who has in-house logistics capabilities. This includes QP services, customs brokerage, warehousing and distribution, and sourcing of clinical trial materials, comparators and rescue medication.
Svitlana Udubkova, BD manager, SanaClis
Tel: +42 191 811 6271